PRSS2 and pancreatic neoplasm: To test this hypothesis, we made use of Tsp-1−/− mice and silenced PRSS2 in the syngeneic C57B6/J-derived pancreatic cancer cell line, Pan02 with 4 unique shRNA sequences44 (Fig. 5B and Supplementary Fig. S8).